|
|
| November 15, 2011: Dr. Stephen Nicholls and Dr. Payal Kohli discuss: SATURN Trial |
Dr. Stephen Nicholls and Dr. Payal Kohli discuss: SATURN Trial: Comparison of
the Progression of Coronary Atherosclerosis for Two High Efficacy Statin Regimens with
Different HDL Effects: SATURN Study Results.
Research support:
AstraZeneca, Anthera, Eli Lilly, Novartis, Resverlogix, Roche and LipoScience
Consulting and honoraria: AstraZeneca, Eli Lilly, Anthera, Omthera, Merck, Takeda,
Resverlogix, Sanofi-Aventis, CSL Behring, Esperion, Boehringer Ingelheim
SATURN was sponsored by AstraZeneca
[ Download video ] |
|
No comments have been submitted
|